The evolving classification of soft tissue tumours: an update based on the new WHO classification, Histopathology, vol.8, issue.1, pp.3-12, 2006. ,
DOI : 10.1097/00000478-200111000-00002
Solitary fibrous tumour and haemangiopericytoma: evolution of a concept, Histopathology, vol.447, issue.1, pp.63-74, 2006. ,
DOI : 10.1097/00000478-199711000-00010
Extrapleural solitary fibrous tumor: a clinicopathologic study of 24 cases, Mod Pathol, vol.12, pp.1034-1042, 1999. ,
New insights into the hemangiopericytoma/solitary fibrous tumor spectrum of tumors, Current Opinion in Oncology, vol.21, issue.4, pp.327-331, 2009. ,
DOI : 10.1097/CCO.0b013e32832c9532
Clinicopathologic correlates of solitary fibrous tumors, Cancer, vol.69, issue.4, pp.1057-1068, 2002. ,
DOI : 10.1002/cncr.10328
Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases ,
Hemangiopericytoma: A 20-year single-institution experience, Annals of Surgical Oncology, vol.214, issue.4, pp.350-355, 1998. ,
DOI : 10.1007/BF02303499
Solitary fibrous tumors of the pleura: clinical characteristics, surgical treatment and outcome, European Journal of Cardio-Thoracic Surgery, vol.21, issue.6, pp.1087-1093, 2002. ,
DOI : 10.1016/S1010-7940(02)00099-4
Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour, Acta Oncologica, vol.151, issue.4, pp.550-554, 2012. ,
DOI : 10.1200/JCO.2008.21.3223
Management of recurrent meningeal hemangiopericytoma, Cancer, vol.21, issue.10, pp.1915-1920, 1998. ,
DOI : 10.1002/(SICI)1097-0142(19980515)82:10<1915::AID-CNCR15>3.0.CO;2-W
Efficacy of trabectedin in metastatic solitary fibrous tumor, Rare Tumors, vol.3, issue.3, p.29, 2011. ,
DOI : 10.4081/rt.2011.e29
Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response Criteria, Journal of Clinical Oncology, vol.25, issue.13, pp.1753-1759, 2007. ,
DOI : 10.1200/JCO.2006.07.3049
Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor, Cancer, vol.27, issue.suppl, pp.4939-4947, 2011. ,
DOI : 10.1002/cncr.26098
Hemangiopericytoma and antiangiogenic therapy: clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed Malignant Haemangioperyctoma /Solitary Fibrous Tumour, Investigational New Drugs, vol.18, issue.4, pp.199-202, 2010. ,
DOI : 10.1007/s10637-009-9249-1
Cancer and immune response: old and new evidence for future challenges, Oncologist, vol.13, pp.1246-1254, 2008. ,
New Guidelines to Evaluate the Response to Treatment in Solid Tumors, JNCI: Journal of the National Cancer Institute, vol.92, issue.3, pp.205-216, 2000. ,
DOI : 10.1093/jnci/92.3.205
Sunitinib malate in solitary fibrous tumor (SFT), Annals of Oncology, vol.23, issue.12, pp.3171-3179, 2012. ,
DOI : 10.1093/annonc/mds143
Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure, European Journal of Cancer, vol.45, issue.11 ,
DOI : 10.1016/j.ejca.2009.02.011
Inhibiting the VEGF???VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor, Current Opinion in Oncology, vol.22, issue.4, pp.351-355, 2010. ,
DOI : 10.1097/CCO.0b013e32833aaad4
Phase II study of sorafenib mesylate (So) in patients (pts) with evolutive and advanced epithelioid hemangioendothelioma (EHE) or hemangiopericytoma/solitary fibrous tumor (SFT), J Clin Oncol, vol.30, p.10020, 2012. ,